0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Original Research |

Comorbidity-Adjusted Life Expectancy: A New Tool to Inform Recommendations for Optimal Screening Strategies

Hyunsoon Cho, PhD; Carrie N. Klabunde, PhD; K. Robin Yabroff, PhD, MBA; Zhuoqiao Wang, MS; Angela Meekins, BS; Iris Lansdorp-Vogelaar, PhD; and Angela B. Mariotto, PhD
[+] Article and Author Information

From the National Cancer Institute, Bethesda, Maryland; Information Services Management, Calverton, Maryland; and Erasmus Medical Center, Rotterdam, the Netherlands.

Disclaimer: The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health, the National Cancer Institute, or the Centers for Disease Control and Prevention.

Grant Support: This study received no external funding. Dr. Lansdorp-Vogelaar was supported by the National Cancer Institute at the National Institutes of Health and the Centers for Disease Control (grants U01-CA-152959 and U01 CA152926.

Potential Conflicts of Interest: None disclosed. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M12-2996.

Reproducible Research Statement: Study protocol: Detailed in the Methods section and Supplement. Statistical code: Available on request. Data set: Restricted. SEER–Medicare data are available to investigators for research purposes through request (see http://appliedresearch.cancer.gov/seermedicare/obtain/).

Requests for Single Reprints: Hyunsoon Cho, PhD, Data Modeling Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD 20892; e-mail, hyunsoon.cho@nih.gov or hyunsoon.cho@gmail.com.

Current Author Addresses: Drs. Cho and Mariotto: Data Modeling Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD 20892.

Drs. Klabunde and Yabroff: Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD 20892.

Mr. Wang and Ms. Meekins: Information Management Services, 3901 Calverton Boulevard, Suite 200, Calverton, MD 20705.

Dr. Lansdorp-Vogelaar: Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, the Netherlands.

Author Contributions: Conception and design: H. Cho, C.N. Klabunde, K.R. Yabroff, A.B. Mariotto.

Analysis and interpretation of the data: H. Cho, C.N. Klabunde, Z. Wang, I. Lansdorp-Vogelaar, A.B. Mariotto.

Drafting of the article: H. Cho, K.R. Yabroff, A.B. Mariotto.

Critical revision of the article for important intellectual content: H. Cho, C.N. Klabunde, K.R. Yabroff, I. Lansdorp-Vogelaar, A.B. Mariotto.

Final approval of the article: H. Cho, C.N. Klabunde, K.R. Yabroff, Z. Wang, I. Lansdorp-Vogelaar, A.B. Mariotto.

Statistical expertise: H. Cho, Z. Wang, A.B. Mariotto.

Administrative, technical, or logistic support: H. Cho.

Collection and assembly of data: H. Cho, A. Meekins.


Ann Intern Med. 2013;159(10):667-676. doi:10.7326/0003-4819-159-10-201311190-00005
Text Size: A A A

Background: Many guidelines recommend considering health status and life expectancy when making cancer screening decisions for elderly persons.

Objective: To estimate life expectancy for elderly persons without a history of cancer, taking into account comorbid conditions.

Design: Population-based cohort study.

Setting: A 5% sample of Medicare beneficiaries in selected geographic areas, including their claims and vital status information.

Participants: Medicare beneficiaries aged 66 years or older between 1992 and 2005 without a history of cancer (n = 407 749).

Measurements: Medicare claims were used to identify comorbid conditions included in the Charlson index. Survival probabilities were estimated by comorbidity group (no, low/medium, and high) and for the 3 most prevalent conditions (diabetes, chronic obstructive pulmonary disease, and congestive heart failure) by using the Cox proportional hazards model. Comorbidity-adjusted life expectancy was calculated based on comparisons of survival models with U.S. life tables. Survival probabilities from the U.S. life tables providing the most similar survival experience to the cohort of interest were used.

Results: Persons with higher levels of comorbidity had shorter life expectancies, whereas those with no comorbid conditions, including very elderly persons, had favorable life expectancies relative to an average person of the same chronological age. The estimated life expectancy at age 75 years was approximately 3 years longer for persons with no comorbid conditions and approximately 3 years shorter for those with high comorbidity relative to the average U.S. population.

Limitations: The cohort was limited to Medicare fee-for-service beneficiaries aged 66 years or older living in selected geographic areas. Data from the Surveillance, Epidemiology, and End Results cancer registry and Medicare claims lack information on functional status and severity of comorbidity, which might influence life expectancy in elderly persons.

Conclusion: Life expectancy varies considerably by comorbidity status in elderly persons. Comorbidity-adjusted life expectancy may help physicians tailor recommendations for stopping or continuing cancer screening for individual patients.

Primary Funding Source: None.

Figures

Grahic Jump Location
Figure 1.

Study flow diagram.

SEER = Surveillance, Epidemiology, and End Results.

* Includes claims between 1991 and 2005. National claims history and outpatient claims were not available before 1991 and cancer diagnosis data used were up to 2005 in the 2008 SEER–Medicare linkage.

Grahic Jump Location
Grahic Jump Location
Figure 2.

Prevalence of comorbidity in the study cohort, by age.

CHF = congestive heart failure; COPD = chronic obstructive pulmonary disease. Top. By comorbidity groups (no, low/medium, or high comorbidity). Bottom. Diabetes, COPD, and CHF. * The prevalence of comorbid conditions (in percentages) in the imputed data were similar.

Grahic Jump Location
Grahic Jump Location
Figure 3.

Estimated survival probabilities for white women aged 75 years, by comorbidity group, compared with the average U.S. white woman: an example of identifying health-adjusted age.

Solid lines represent survival probabilities estimated from the model for white women at age 75 years, by comorbidity, and dashed lines represent survival probabilities from the best matching U.S. life table. CHF = congestive heart failure; COPD = chronic obstructive pulmonary disease. Top. Comorbidity groups (no, low/medium, or high comorbidity). Bottom. Diabetes, COPD, and CHF.

* Includes diabetes only or diabetes with other conditions except COPD and CHF.

† Includes COPD only or COPD with other conditions except CHF.

‡ Includes CHF only or CHF with other conditions.

Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Journal Club
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)